Name: Mangoceuticals, Inc. (MGRX) Cash Flow Statement
Creator: FinSpry

Mangoceuticals Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for Mangoceuticals, Inc. (MGRX) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Operating Activities
Net Income	-8.71	-9.21	-2.00	-0.07
Depreciation & Amortization	0.73	0.02	0.00	0.00
Stock Based Compensation	2.35	2.16	0.77	0.00
Change in Working Capital	0.66	-0.01	0.02	0.00
Change in Inventory	0.00	-0.02	0.00	0.00
Change in Accounts Payable	0.70	0.11	0.03	0.00
Change in Other Working Capital	-0.04	-0.10	-0.01	0.00
Other Operating Activities	0.08	0.05	-0.15	0.00
Net Cash from Operating Activities	-4.86	-7.00	-1.35	-0.07
Investing Activities
Capital Expenditures	0.00	0.00	-0.04	0.00
Other Investing Activities	0.07	0.00	0.00	0.00
Net Cash from Investing Activities	0.07	0.00	-0.04	0.00
Financing Activities
Debt Repayment	0.15	-0.17	-0.03	0.00
Common Stock Issued	1.33	7.22	2.00	0.00
Dividends Paid	-0.80	0.00	0.00	0.00
Other Financing Activities	3.45	0.00	0.00	0.00
Net Cash from Financing Activities	4.13	7.06	2.05	0.16
Summary
Effect of Forex Changes on Cash	-0.01	0.00	0.00	0.00
Net Change in Cash	-0.68	0.06	0.66	0.09
Cash at Beginning of Period	0.74	0.68	0.02	0.00
Cash at End of Period	0.06	0.74	0.68	0.00
Free Cash Flow	-4.86	-7.00	-1.39	-0.07